Presence of p24-Antigen associated to erythrocyte in HIV-positive individuals even in patients with undetectable plasma viral load

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Garcia, Maria Noé ^a   dos Ramos Farias, Maria Sol ^a   Ávila, Maria Mercedes ^a   Rabinovich, Roberto Daniel ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; TANNIN; VIRUS PROTEIN; GAG PROTEIN; VIRUS ANTIGEN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; IN VITRO STUDY; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; PATIENT SELECTION; VIRUS EXPRESSION; VIRUS LOAD; VIRUS PURIFICATION; BLOOD; METABOLISM; VIROLOGY;

ANTIGENS, VIRAL; ERYTHROCYTES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; VIRAL LOAD;

EID: 79251587536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014544     Document Type: Article

References (21)

1. Nelson RA Jr. (1953) The immune-adherence phenomenon: an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science 118: 733-7.
2. Schifferli JA, Ng YC, Peters DK (1986) The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 315: 488-95.
3. Schifferli JA, Ng YC, Estreicher J, Walport MJ (1988) The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. J Immunol 140: 899-904.
4. Horakova E, Gasser O, Sadallah S, Inal JM, Bourgeois G, et al. (2004) Complement mediates the binding of HIV to erythrocytes. J Inmunol 173: 4236-41.
5. Lachgar A, Jaureguiberry G, Le Buenac H, Bizzini B, Zagury JF, et al. (1998) Binding of HIV-l to RBCs involves the Duffy antigen receptors for chemokines (DARC). Biomed Pharmacother 52: 436-9.
6. He W, Neil S, Kulkarni H, Wright E, Agan BK, et al. (2008) Duffy Antigen Receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 4: 52-62.
7. Beck Z, Brown BK, Wieczorek L, Peachman KK, Matyas GR, et al. (2009) Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions. PLoS One 4(12): e8297.
8. Tausk FA, McCutchan A, Spechko P, Schreiber RD, Gigli I (1986) Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest 78: 977-82.
9. Cohen JH, Autran B, Jouvin MH, Aubry JP, Rozenbaum W, et al. (1988) Decrease of erythrocyte receptors for the C3b fragment of complement in acquired immunodeficiency syndrome. Presse Med 17: 727-30.
10. Olinger G, Saifuddin M, Spear G (2000) CD4-negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells. J Virol 74: 8550-7.
11. Hess C, Klimkait T, Schlapbach L, Del Zenero V, Sadallah S, et al. (2002) Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study. Lancet 359: 2230-4.
12. Bánki Z, Wilflingseder D, Ammann CG, Pruenster M, Müllauer B, et al. (2006) Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells. J Immunol 177: 3469-76.
13. Fierer DS, Vargas J Jr., Patel N, Clover G (2007) Absence of erythocyteassociated HIV-1 in vivo. J Infect Dis 196: 587-90.
14. Schüpbach J (2003) Viral RNA and p24 antigen as markers of HIV disease and antiretroviral treatment success. Int Arch Allergy Immunol 132(3): 196-209.
15. Gulzar N, Diker B, Mihowich J, Deschatelets J, Arsenault ME, et al. (2008) Proportion of HIV-1 infected CD8+CD4- T lymphocytes in vivo. Curr HIV Res 6(6): 585-96.
16. Terpos E, Sarantopoulos A, Kouramba A, Katsarou O, Stavropoulos J, et al. (2008) Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection. Med Sci Monit 14: CR276-80.
17. Schüpbach J, Günthard H, Joos B, Fischer M, Böni J, et al. (2005) HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. J Acquir Immune Defic Syndr 40: 250-6.
18. Schüpbach J (2002) Measurement of HIV-1 p24 antigen by signal-amplificationboosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. AIDS Rev 4: 83-92.
19. dos Ramos Farías MS, Garcia MN, Dilernia D, Rabinovich RD, Avila MM (2009) Centrifugation improves the detection of HIV-1 p24 antigen in plasma from children born to mothers infected with HIV-1. J Virol Methods 158: 6-10.
20. Alexaki A, Liu Y, Wigdahl B (2008) Cellular Reservoirs of HIV-1 and their Role in Viral Persistence. Curr HIV Res 6(5): 388-400.
21. Prado JG, Shintani A, Bofill M, Clotet B, Ruiz L, et al. (2004) Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic HIV infection during structured treatment interruptions. J Clin Microbiol 42: 1620-5.